Pioneering cell therapy offers hope for advanced liver disease
A new type of cell therapy shows promise as the first treatment for advanced liver disease, following results from a clinical trial.
A new type of cell therapy shows promise as the first treatment for advanced liver disease, following results from a clinical trial.
Changes in land-use across Southeast Asia over the past 15 years are worsening air quality and contributing to thousands of excess deaths each year, according to a study led by…
Nonalcoholic fatty liver disease (NAFLD) is a prevalent metabolic disorder with a complex pathogenesis. Although epitranscriptomic modifications such as N6-methyladenosine (m6A) have been implicated in NAFLD, the role of N1-methyladenosine…
Sydney's life sciences sector has reached a major milestone, with Kurraba Group announcing the first confirmed partners for ION – a purpose-built commercial life sciences precinct set to redefine innovation…
Targeting senescent cells with dasatinib-quercetin preserves disc structure and modulates degeneration-associated pathways in a mouse model.
An EHU study says that vitamin D supplements can help to strengthen the immune system, but not to improve athletic performance.
Recently, a research team led by Professors Dahong Zhang and Qi Zhang from the Urology Department and the Institute of Urology at Zhejiang Provincial People's Hospital and the Translational Medicine…
A new wave of scientific understanding is placing ferroptosis, a distinct form of iron-dependent cell death, at the forefront of efforts to overcome drug resistance in digestive cancers. These cancers,…
Substantial and sustained weight-loss has been linked to a reduced risk of cancer and cancer-related death, mainly in women. Two new studies now provide clues to why the risk is…
A new review article highlights the expanding importance of glutamine metabolism in shaping the tumor microenvironment, offering fresh perspectives on how metabolic interactions influence cancer progression and therapeutic response